Treatment of advanced or metastatic hepatocellular cancer (HCC): Interim analysis of a single-arm phase II study of bevacizumab and RAD001. Background: The ToGA study established the benefit of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback